Reducing empiric piperacillin-tazobactam use for patients with community-acquired intra-abdominal infections.

Wilson C, Epps K, Willis C, Mendez J, Kim J, St Clair J, Cowdell JC.

Open source

DOI
10.1017/ash.2026.10391
Published
2026-04-28
Container
Antimicrob Steward Healthc Epidemiol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1017/ash.2026.10391,
  title = {Reducing empiric piperacillin-tazobactam use for patients with community-acquired intra-abdominal infections.},
  author = {Wilson C and  Epps K and  Willis C and  Mendez J and  Kim J and  St Clair J and  Cowdell JC.},
  year = {2026},
  journal = {Antimicrob Steward Healthc Epidemiol},
  doi = {10.1017/ash.2026.10391},
  url = {https://doi.org/10.1017/ash.2026.10391}
}

RIS

TY  - JOUR
TI  - Reducing empiric piperacillin-tazobactam use for patients with community-acquired intra-abdominal infections.
AU  - Wilson C
AU  -  Epps K
AU  -  Willis C
AU  -  Mendez J
AU  -  Kim J
AU  -  St Clair J
AU  -  Cowdell JC.
PY  - 2026
JO  - Antimicrob Steward Healthc Epidemiol
DO  - 10.1017/ash.2026.10391
UR  - https://doi.org/10.1017/ash.2026.10391
ER  - 

APA

C, W., K, E., C, W., J, M., J, K., J, S. C., & JC., C. (2026). Reducing empiric piperacillin-tazobactam use for patients with community-acquired intra-abdominal infections.. Antimicrob Steward Healthc Epidemiol. https://doi.org/10.1017/ash.2026.10391

Source records